CyanVaccine Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $47.1M

  • Investors
  • 4

CyanVaccine General Information

Description

Developer of vaccines designed for respiratory diseases. The company develops vaccines to treat PIV5 virus, enabling human-beings to live a healthier life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1st Floor, Building 2
  • No. 6, Nanjiang 2nd Road, Zhujiang Street, Nansha District
  • Guangzhou, Guangdong
  • China
+86 020
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • 1st Floor, Building 2
  • No. 6, Nanjiang 2nd Road, Zhujiang Street, Nansha District
  • Guangzhou, Guangdong
  • China
+86 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CyanVaccine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 26-Jan-2022 $47.1M Completed Clinical Trials - Phase 1
3. Early Stage VC 01-Jan-2021 Completed Startup
2. Early Stage VC 01-Jun-2020 Completed Startup
1. Seed Round 01-Apr-2020 Completed Clinical Trials - Phase 1
To view CyanVaccine’s complete valuation and funding history, request access »

CyanVaccine Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sunz Fund Venture Capital Minority
Zhongda Venture Capital Venture Capital Minority
Wuhan Optics Valley Elite Investment Management Venture Capital Minority
Changchun High and New Technology Industries Group Corporation Minority
To view CyanVaccine’s complete investors history, request access »

CyanVaccine FAQs

  • When was CyanVaccine founded?

    CyanVaccine was founded in 2019.

  • Where is CyanVaccine headquartered?

    CyanVaccine is headquartered in Guangzhou, China.

  • What industry is CyanVaccine in?

    CyanVaccine’s primary industry is Drug Discovery.

  • Is CyanVaccine a private or public company?

    CyanVaccine is a Private company.

  • What is the current valuation of CyanVaccine?

    The current valuation of CyanVaccine is .

  • What is CyanVaccine’s current revenue?

    The current revenue for CyanVaccine is .

  • How much funding has CyanVaccine raised over time?

    CyanVaccine has raised $47.1M.

  • Who are CyanVaccine’s investors?

    Sunz Fund, Zhongda Venture Capital, Wuhan Optics Valley Elite Investment Management, and Changchun High and New Technology Industries Group have invested in CyanVaccine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process